Outpatient Clinic of the Diabetic Foot, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece University of Manchester and Manchester Diabetes Centre, Manchester, UK.
Diabet Med. 2013 May;30(5):525-34. doi: 10.1111/dme.12000.
A simple non-invasive indicator test (Neuropad(®)) has been developed for the assessment of sweating and, hence, cholinergic innervation in the diabetic foot. The present review summarizes current knowledge on this diagnostic test. The diagnostic ability of this test is based on a colour change from blue to pink at 10 min, with excellent reproducibility, which lends itself to patient self-examination. It has a high sensitivity (65.1-100%) and negative predictive value (63-100%), with moderate specificity (32-78.5%) and positive predictive value (23.3-93.2%) for the diagnosis of diabetic peripheral neuropathy. It also has moderate to high sensitivity (59.1-89%) and negative predictive value (64.7-91%), but low to moderate specificity (27-78%) and positive predictive value (24-48.6%) for the diagnosis of diabetic cardiac autonomic neuropathy. There are some data to suggest that Neuropad can detect early diabetic neuropathy, but this needs further evaluation. It remains to be established whether this test can predict foot ulceration and amputation, thereby contributing to the identification of high-risk patients.
一种简单的无创指标检测(Neuropad(®))已经被开发出来,用于评估糖尿病患者的出汗情况,从而评估其胆碱能神经支配。本文综述了该诊断检测的现有知识。该检测基于 10 分钟时从蓝色变为粉红色的颜色变化,具有极好的重现性,非常适合患者自我检查。它对糖尿病周围神经病变的诊断具有较高的敏感性(65.1-100%)和阴性预测值(63-100%),中等特异性(32-78.5%)和阳性预测值(23.3-93.2%)。它对糖尿病心脏自主神经病变的诊断也具有中等至高的敏感性(59.1-89%)和阴性预测值(64.7-91%),但特异性较低(27-78%)和阳性预测值(24-48.6%)。有一些数据表明,Neuropad 可以检测早期糖尿病神经病变,但这需要进一步评估。该检测是否可以预测足部溃疡和截肢,从而有助于识别高危患者,仍有待确定。